Education
About Us
Working with TipRanks
Follow Us
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
CDTX Analyst Ratings
Hold
2 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CDTX Stock 12 Month Forecast
Average Price Target
$209.67
▼(-4.52% Downside)
| Highest Price Target$221.50 | Average Price Target$209.67 | Lowest Price Target$173.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Guggenheim
$167→$221.5
Hold
0.87%
Upside
Downgraded
11/17/25
H.C. Wainwright
―
Hold
―
Downgraded
11/17/25
Morgan Stanley
$190→$221.5
Hold
0.87%
Upside
Downgraded
11/16/25
Needham
―
Hold
―
Downgraded
11/14/25
J.P. Morgan
$200→$221.5
Hold
0.87%
Upside
Downgraded
11/14/25
RBC Capital
$145→$221.5
Hold
0.87%
Upside
Downgraded
11/14/25
WBB Securities
$123→$199
Buy
-9.38%
Downside
Reiterated
10/09/25
Citizens JMP
$153→$173
Buy
-21.22%
Downside
Reiterated
10/03/25
Cantor Fitzgerald
―
Buy
―
Reiterated
06/10/25
Truist Financial
$31→$35
Buy
-84.06%
Downside
Reiterated
05/22/25
Westpark Capital
$35
Buy
-84.06%
Downside
Reiterated
03/10/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Guggenheim
$167→$221.5
Hold
0.87%
Upside
Downgraded
11/17/25
H.C. Wainwright
―
Hold
―
Downgraded
11/17/25
Morgan Stanley
$190→$221.5
Hold
0.87%
Upside
Downgraded
11/16/25
Needham
―
Hold
―
Downgraded
11/14/25
J.P. Morgan
$200→$221.5
Hold
0.87%
Upside
Downgraded
11/14/25
RBC Capital
$145→$221.5
Hold
0.87%
Upside
Downgraded
11/14/25
WBB Securities
$123→$199
Buy
-9.38%
Downside
Reiterated
10/09/25
Citizens JMP
$153→$173
Buy
-21.22%
Downside
Reiterated
10/03/25
Cantor Fitzgerald
―
Buy
―
Reiterated
06/10/25
Truist Financial
$31→$35
Buy
-84.06%
Downside
Reiterated
05/22/25
Westpark Capital
$35
Buy
-84.06%
Downside
Reiterated
03/10/25
Best Analysts Covering Cidara Therapeutics
1 Month
xxx
Success Rate
9/10 ratings generated profit
Average Return
+26.10%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 90.00% of your transactions generating a profit, with an average return of +26.10% per trade.
3 Months
xxx
Success Rate
8/10 ratings generated profit
Average Return
+54.65%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +54.65% per trade.
1 Year
Success Rate
7/10 ratings generated profit
Average Return
+218.41%
reiterated a buy rating 2 months ago
Copying Stephen Brozak's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +218.41% per trade.
2 Years
xxx
Success Rate
7/10 ratings generated profit
Average Return
+219.49%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 70.00% of your transactions generating a profit, with an average return of +219.49% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CDTX Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
6
4
10
9
6
Buy
12
11
13
11
6
Hold
5
3
4
7
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
18
27
27
20
Each month's total comprises the sum of three months' worth of ratings.
CDTX Financial Forecast
CDTX Stock Forecast FAQ
What is CDTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Cidara Therapeutics’s 12-month average price target is 209.67.
What is CDTX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CDTX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CDTX a Buy, Sell or Hold?
Cidara Therapeutics has a consensus rating of Hold which is based on 2 buy ratings, 6 hold ratings and 0 sell ratings.
What is Cidara Therapeutics’s price target?
The average price target for Cidara Therapeutics is 209.67. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $221.50 ,the lowest forecast is $173.00. The average price target represents -4.52% Decrease from the current price of $219.6.
The highest analyst price target is $221.50 ,the lowest forecast is $173.00. The average price target represents -4.52% Decrease from the current price of $219.6.
What do analysts say about Cidara Therapeutics?
Cidara Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of CDTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.